http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0226232-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a00187087f2fcd60db0ba63da7d1862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff09a096cd24e7c3730d9c9ed16972fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7ed71a6a9351035a84adcd6b2d18e9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f79a8d33c6a880e47ebe4bd172ded11d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
filingDate 2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f9e462bb13d9a19bd4c4a7a5b82f84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0f37bdc8fe9ad5f0e4cae0c8787b15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c34576face0cf08ed47d491ff46aca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c06d53074fcb6d04a4a7bffbf946d4
publicationDate 2002-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0226232-A1
titleOfInvention Pharmaceutical composition for transmucosal delivery of a dihydroergotamine/metoclopramide combination
abstract The invention concerns a novel pharmaceutical composition for transmucosal delivery of a dihydroergotamine/metoclopramide combination.
priorityDate 2000-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9815275-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8303759-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6426689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66583097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128972812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129313279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226524923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226561306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226501765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11989722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4168

Total number of triples: 43.